Compared to non‐Type 2 inflammatory asthma patients, severe asthma patients with Type 2 inflammation demonstrate a significant reduction in the expression of claudin‐18 and E‐cadherin in bronchial biopsies. This evidence concerns the gene CDH1 and asthma.